- Trials with a EudraCT protocol (2)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2 result(s) found for: T502-SIT-045.
Displaying page 1 of 1.
EudraCT Number: 2022-004082-20 | Sponsor Protocol Number: T502-SIT-059 | Start Date*: 2023-03-07 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: An open phase III follow-up study in patients previously treated with mannan-conjugated birch pollen allergoids or placebo in the T502-045 trial. | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinoconjunctivitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002252-36 | Sponsor Protocol Number: T502-SIT-045 | Start Date*: 2021-10-27 | |||||||||||
Sponsor Name:Inmunotek S.L. | |||||||||||||
Full Title: A prospective, randomized, double-blind placebo-controlled multicentre study with 10 000 mTU/mL mannan-conjugated birch pollen allergoids administered subcutaneously to patients with birch pollen-i... | |||||||||||||
Medical condition: Treatment of birch pollen-induced allergic rhinitis or rhinoconjunctivitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
